{"id":"https://openalex.org/W7225330259","doi":"https://doi.org/10.21203/rs.3.rs-11446928/v1","title":"Genomic Alterations and Pathologic Responses to Androgen Receptor Pathway Inhibitor Doublets vs. Triplets in the Phase-II Genomic Umbrella Neoadjuvant Study (GUNS) in High-Risk Localized Prostate Cancer","display_name":"Genomic Alterations and Pathologic Responses to Androgen Receptor Pathway Inhibitor Doublets vs. Triplets in the Phase-II Genomic Umbrella Neoadjuvant Study (GUNS) in High-Risk Localized Prostate Cancer","publication_year":2026,"publication_date":"2026-11-05","ids":{"openalex":"https://openalex.org/W7225330259","doi":"https://doi.org/10.21203/rs.3.rs-11446928/v1"},"language":"en","primary_location":{"id":"doi:10.21203/rs.3.rs-11446928/v1","doi":"https://doi.org/10.21203/rs.3.rs-11446928/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-11446928/v1","pdf_url":"https://www.researchsquare.com/article/rs-11446928/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.researchsquare.com/article/rs-11446928/latest.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062125605","display_name":"Martin Edwin Gleave","orcid":"https://orcid.org/0000-0003-4235-0167","observed_orcids":["https://orcid.org/0000-0003-4235-0167"]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]},{"id":"https://openalex.org/I4405261103","display_name":"Vancouver Prostate Centre","ror":"https://ror.org/04skhpe58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4405261103"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Martin Gleave","raw_affiliation_strings":["The Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia","institution_ids":["https://openalex.org/I141945490","https://openalex.org/I4405261103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024874902","display_name":"Joshua Scurll","orcid":"https://orcid.org/0009-0007-5855-0127","observed_orcids":["https://orcid.org/0009-0007-5855-0127"]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Joshua Scurll","raw_affiliation_strings":["Department of Urologic Sciences, University of British Columbia"],"raw_orcid":"https://orcid.org/0009-0007-5855-0127","affiliations":[{"raw_affiliation_string":"Department of Urologic Sciences, University of British Columbia","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047882814","display_name":"Himisha Beltran","orcid":"https://orcid.org/0000-0003-3259-2226","observed_orcids":["https://orcid.org/0000-0003-3259-2226"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Himisha Beltran","raw_affiliation_strings":["Dana Farber Cancer Institute and Harvard Medical School"],"raw_orcid":"https://orcid.org/0000-0003-3259-2226","affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute and Harvard Medical School","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017780203","display_name":"Eric Charles Belanger","orcid":"https://orcid.org/0000-0003-2785-0729","observed_orcids":["https://orcid.org/0000-0003-2785-0729"]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Eric Belanger","raw_affiliation_strings":["The University of British Columbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of British Columbia","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051781768","display_name":"Htoo Zarni Oo","orcid":"https://orcid.org/0009-0009-8514-2713","observed_orcids":["https://orcid.org/0009-0009-8514-2713"]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Htoo Zarni Oo","raw_affiliation_strings":["1.\tDepartment of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada"],"raw_orcid":"https://orcid.org/0009-0009-8514-2713","affiliations":[{"raw_affiliation_string":"1.\tDepartment of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5149070767","display_name":"Alexander Wyatt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Alexander Wyatt","raw_affiliation_strings":["University of British Columbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of British Columbia","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5128952564","display_name":"Miles Mannas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Miles Mannas","raw_affiliation_strings":["University of British Columbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of British Columbia","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050196540","display_name":"Peter C. Black","orcid":"https://orcid.org/0000-0002-2919-7068","observed_orcids":["https://orcid.org/0000-0002-2919-7068"]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Peter Black","raw_affiliation_strings":["UBC"],"raw_orcid":"https://orcid.org/0000-0002-2919-7068","affiliations":[{"raw_affiliation_string":"UBC","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081653545","display_name":"Amina Zoubeidi","orcid":"https://orcid.org/0000-0002-0498-142X","observed_orcids":["https://orcid.org/0000-0002-0498-142X"]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Amina Zoubeidi","raw_affiliation_strings":["University of British Columbia"],"raw_orcid":"https://orcid.org/0000-0002-0498-142X","affiliations":[{"raw_affiliation_string":"University of British Columbia","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5127813532","display_name":"Jonathan Ma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405261103","display_name":"Vancouver Prostate Centre","ror":"https://ror.org/04skhpe58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4405261103"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jonathan Ma","raw_affiliation_strings":["Vancouver Prostate Centre"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vancouver Prostate Centre","institution_ids":["https://openalex.org/I4405261103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001885553","display_name":"Doron Berlin","orcid":"https://orcid.org/0000-0002-2763-6848","observed_orcids":["https://orcid.org/0000-0002-2763-6848"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Doron Berlin","raw_affiliation_strings":["University Health Network"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Health Network","institution_ids":["https://openalex.org/I1325899441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006953902","display_name":"Susan Prendeville","orcid":"https://orcid.org/0000-0002-1068-355X","observed_orcids":["https://orcid.org/0000-0002-1068-355X"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Susan Prendeville","raw_affiliation_strings":["University Health Network"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Health Network","institution_ids":["https://openalex.org/I1325899441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160920988","display_name":"Di Jiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Di Jiang","raw_affiliation_strings":["University Health Network"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Health Network","institution_ids":["https://openalex.org/I1325899441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050166344","display_name":"Brant Allen Inman","orcid":"https://orcid.org/0000-0002-6060-4485","observed_orcids":["https://orcid.org/0000-0002-6060-4485"]},"institutions":[{"id":"https://openalex.org/I2800925808","display_name":"London Health Sciences Centre","ror":"https://ror.org/037tz0e16","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800925808"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Brant Inman","raw_affiliation_strings":["London Health Sciences Centre"],"raw_orcid":"https://orcid.org/0000-0002-6060-4485","affiliations":[{"raw_affiliation_string":"London Health Sciences Centre","institution_ids":["https://openalex.org/I2800925808"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081777867","display_name":"Brian Francis Chapin","orcid":"https://orcid.org/0000-0003-3225-9976","observed_orcids":["https://orcid.org/0000-0003-3225-9976"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Chapin","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027920712","display_name":"Todd Matthew Morgan","orcid":"https://orcid.org/0000-0002-1140-0603","observed_orcids":["https://orcid.org/0000-0002-1140-0603"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Todd Morgan","raw_affiliation_strings":["University of Michigan"],"raw_orcid":"https://orcid.org/0000-0002-1140-0603","affiliations":[{"raw_affiliation_string":"University of Michigan","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091728470","display_name":"Zachery Roger Reichert","orcid":"https://orcid.org/0000-0003-0356-8796","observed_orcids":["https://orcid.org/0000-0003-0356-8796"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zachery Reichert","raw_affiliation_strings":["University of Michigan"],"raw_orcid":"https://orcid.org/0000-0003-0356-8796","affiliations":[{"raw_affiliation_string":"University of Michigan","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072104844","display_name":"Adam Stuart Kibel","orcid":"https://orcid.org/0000-0002-9446-7781","observed_orcids":["https://orcid.org/0000-0002-9446-7781"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam Kibel","raw_affiliation_strings":["Urology Division, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Urology Division, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082241725","display_name":"Marc Dall\u2019Era","orcid":"https://orcid.org/0000-0002-2301-2683","observed_orcids":["https://orcid.org/0000-0002-2301-2683"]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc Dall\u2019Era","raw_affiliation_strings":["University of California Davis Comprehensive Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California Davis Comprehensive Cancer Center","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005802303","display_name":"Mamta Parikh","orcid":"https://orcid.org/0000-0002-7300-7452","observed_orcids":["https://orcid.org/0000-0002-7300-7452"]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mamta Parikh","raw_affiliation_strings":["University of California Davis Comprehensive Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California Davis Comprehensive Cancer Center","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159855768","display_name":"Michael Schweizer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Schweizer","raw_affiliation_strings":["University of Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028739613","display_name":"Daniel Lin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Lin","raw_affiliation_strings":["Department of Urology, University of Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, University of Washington","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159127532","display_name":"Rodney Breau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I153718931","display_name":"University of Ottawa","ror":"https://ror.org/03c4mmv16","country_code":"CA","type":"education","lineage":["https://openalex.org/I153718931"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Rodney Breau","raw_affiliation_strings":["University of Ottawa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Ottawa","institution_ids":["https://openalex.org/I153718931"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086407520","display_name":"Lucia Nappi","orcid":"https://orcid.org/0000-0002-4365-7251","observed_orcids":["https://orcid.org/0000-0002-4365-7251"]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Lucia Nappi","raw_affiliation_strings":["University of British Columbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of British Columbia","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007710281","display_name":"Neil Eric Fleshner","orcid":"https://orcid.org/0000-0001-7407-7463","observed_orcids":["https://orcid.org/0000-0001-7407-7463"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Neil Fleshner","raw_affiliation_strings":["University Health Network"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Health Network","institution_ids":["https://openalex.org/I1325899441"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/high-risk-localized-prostate-cancer","display_name":"high-risk localized prostate cancer","score":0.9160000085830688},{"id":"https://openalex.org/keywords/androgen-receptor-pathway-inhibitors","display_name":"androgen receptor pathway inhibitors","score":0.925000011920929},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.968999981880188},{"id":"https://openalex.org/keywords/apalutamide","display_name":"apalutamide","score":0.8539999723434448},{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":0.9929999709129333},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9660000205039978},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.781000018119812},{"id":"https://openalex.org/keywords/ets-gene-fusions","display_name":"ETS gene fusions","score":0.859000027179718},{"id":"https://openalex.org/keywords/foxa1","display_name":"FOXA1","score":0.9269999861717224},{"id":"https://openalex.org/keywords/tp53","display_name":"TP53","score":0.878000020980835},{"id":"https://openalex.org/keywords/pten","display_name":"PTEN","score":0.9829999804496765},{"id":"https://openalex.org/keywords/speckle-type-poz-protein","display_name":"SPOP","score":0.9150000214576721},{"id":"https://openalex.org/keywords/rb1","display_name":"RB1","score":0.7509999871253967},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.5019999742507935},{"id":"https://openalex.org/keywords/pten-mutation","display_name":"PTEN mutation","score":0.5609999895095825},{"id":"https://openalex.org/keywords/genetic-alterations","display_name":"genetic alterations","score":0.593999981880188},{"id":"https://openalex.org/keywords/major-pathologic-response","display_name":"major pathological response","score":0.8180000185966492},{"id":"https://openalex.org/keywords/residual-cancer-burden","display_name":"residual cancer burden","score":0.9800000190734863}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7286999821662903},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.7095000147819519},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.6837999820709229},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6556000113487244},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5212000012397766},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5145000219345093},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.478300005197525},{"id":"https://openalex.org/C154456304","wikidata":"https://www.wikidata.org/wiki/Q18027046","display_name":"FOXA1","level":4,"score":0.4699000120162964},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.45089998841285706},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.44749999046325684},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4325000047683716},{"id":"https://openalex.org/C2779322244","wikidata":"https://www.wikidata.org/wiki/Q574820","display_name":"Antiandrogen","level":4,"score":0.3846000134944916},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3573000133037567},{"id":"https://openalex.org/C2777911890","wikidata":"https://www.wikidata.org/wiki/Q62614","display_name":"Androgen","level":3,"score":0.35040000081062317},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.3467000126838684},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.3359000086784363},{"id":"https://openalex.org/C2776071976","wikidata":"https://www.wikidata.org/wiki/Q14912280","display_name":"CHEK2","level":5,"score":0.30640000104904175},{"id":"https://openalex.org/C111425858","wikidata":"https://www.wikidata.org/wiki/Q14911708","display_name":"MLH1","level":5,"score":0.2924000024795532},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2847000062465668},{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.27720001339912415},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.2759999930858612},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.26989999413490295}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.21203/rs.3.rs-11446928/v1","doi":"https://doi.org/10.21203/rs.3.rs-11446928/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-11446928/v1","pdf_url":"https://www.researchsquare.com/article/rs-11446928/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.21203/rs.3.rs-11446928/v1","doi":"https://doi.org/10.21203/rs.3.rs-11446928/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-11446928/v1","pdf_url":"https://www.researchsquare.com/article/rs-11446928/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225330259.pdf","grobid_xml":"https://content.openalex.org/works/W7225330259.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7133185937","https://openalex.org/W4407701510","https://openalex.org/W4407699195","https://openalex.org/W7172533688","https://openalex.org/W4391302564","https://openalex.org/W4408225802","https://openalex.org/W7136237616","https://openalex.org/W7117322425","https://openalex.org/W2794100863","https://openalex.org/W7172208853"],"abstract_inverted_index":{"Abstract":[0],"GUNS":[1],"(NCT04812366)":[2],"is":[3],"a":[4,195,272,330],"multi-centre":[5],"adaptive":[6],"umbrella":[7],"phase-II":[8],"neoadjuvant":[9],"trial":[10],"evaluating":[11],"24":[12],"weeks":[13,72,103],"of":[14,47,73,104,187,391],"biomarker-directed":[15],"therapy":[16,80,134,162,229,264],"on":[17],"major":[18],"pathologic":[19,172,337],"response":[20,173],"(MPR)":[21],"and":[22,65,171,182,210,236,302,316,319,376],"residual":[23],"cancer":[24,33],"burden":[25],"(RCB)":[26],"in":[27,180,184,191,220,275,295,324,339,366,379,386],"men":[28,88,114,143,178,380],"with":[29,81,107,115,144,163,223,257,271,329,348,364,381],"high-risk":[30],"localized":[31],"prostate":[32],"(HR-LPC)":[34],"undergoing":[35],"radical":[36],"prostatectomy.":[37],"MPR":[38,216,253,374],"was":[39,217,239,254,345],"defined":[40,94],"by":[41,95,199],"\u2264":[42,54],"5":[43],"mm":[44,56,245,281],"longest":[45],"diameter":[46],"the":[48,335],"dominant":[49],"focus":[50],"or":[51,108,123],"viable":[52],"RCB":[53,238,277,350,377],"1":[55],"2":[57,246,282],".":[58],"Diagnostic":[59],"biopsies":[60],"underwent":[61],"Tempus\u2019":[62],"648-gene":[63],"DNA":[64],"whole-transcriptome":[66],"RNA":[67],"sequencing":[68],"(seq).":[69],"After":[70],"8":[71],"androgen":[74,82],"receptor":[75],"pathway":[76],"inhibitor":[77],"(ARPI)":[78],"doublet":[79,227,262],"deprivation":[83],"(ADT)":[84],"plus":[85],"apalutamide":[86],"(APA),":[87],"were":[89,357,361],"assigned":[90],"to":[91,128,157,312,388],"sub-protocols":[92],"(SPs)":[93],"genomic":[96,126,146,170,196],"alterations":[97,127,147],"(alt)":[98],"for":[99,175],"an":[100,105],"additional":[101,110],"16":[102],"ARPI-doublet":[106,130,158],"without":[109],"therapy.":[111],"SP-1":[112,181],"randomized":[113,142],"AR-associated":[116],"(ETS":[117],"fusions,":[118],"FOXA1":[119,204,320],",":[120,150,152,154,247,283],"SPOP":[121,211,317],")":[122,156],"otherwise":[124],"favourable":[125],"continue":[129],"(SP-1A)":[131,228],"versus":[132,160,226,261],"triplet":[133,161,224,259],"that":[135,360],"includes":[136],"another":[137],"ARPI,":[138],"abiraterone":[139],"(SP-1B).":[140],"SP-2":[141],"aggressive":[145],"(":[148],"RB1":[149],"PTEN":[151,208],"TP53":[153,206],"AKT1":[155],"(SP-2A)":[159,263],"docetaxel":[164,365],"chemotherapy":[165],"(SP-2B).":[166],"This":[167],"analysis":[168],"reports":[169],"data":[174],"100":[176],"evaluable":[177],"enrolled":[179,190],"48":[183],"SP-2,":[185,252],"out":[186],"322":[188],"participants":[189],"GUNS.":[192],"DNA-seq":[193],"revealed":[194],"landscape":[197],"dominated":[198],"ETS":[200,332],"gene":[201],"fusions":[202,310],"(41%),":[203],"(22%),":[205],"(19%),":[207],"(15%),":[209],"(12%)":[212],"alterations.":[213],"In":[214,251,368],"SP-1,":[215,325],"significantly":[218,255],"higher":[219,256,314],"patients":[221],"treated":[222],"(SP-1B)":[225],"(58%":[230],"vs.":[231,243,266,279,297,300,304,307],"32%,":[232],"p":[233,248,268,284],"=":[234,249,269,285],"0.0045)":[235],"overall":[237],"lower":[240,294,322,349],"(median":[241],"0.73":[242],"2.79":[244],"0.012).":[250],"ARPI-docetaxel":[258],"(SP-2B)":[260],"(25%":[265],"0%,":[267],"0.011)":[270],"4.6-fold":[273],"reduction":[274],"median":[276],"(7.6":[278],"34.6":[280],"0.083).":[286],"Secondary":[287],"endpoints":[288],"included":[289],"ypN1":[290],"rates,":[291],"which":[292],"trended":[293],"SP-1B":[296],"SP-1A":[298],"(14%":[299],"28%)":[301],"SP-2B":[303],"SP-2A":[305],"(29%":[306],"46%).":[308],"ERG":[309],"tended":[311],"have":[313],"RCB,":[315,323],"alt":[318,321],"while":[326,354],"PTEN-deficient":[327],"tumours":[328],"concurrent":[331],"fusion":[333],"had":[334],"worst":[336],"outcomes":[338],"SP-2.":[340],"Transcriptomically,":[341],"baseline":[342],"AR":[343],"signalling":[344],"strongly":[346],"associated":[347],"following":[351],"ARPI-only":[352],"combinations,":[353],"immunological":[355],"signatures":[356],"unfavourable,":[358],"associations":[359],"not":[362],"seen":[363],"SP-2B.":[367],"conclusion,":[369],"genomic-biomarker-directed":[370],"ARPI-triplet":[371],"therapies":[372],"improve":[373],"rates":[375],"distributions":[378],"HR-LPC,":[382],"supporting":[383],"further":[384],"validation":[385],"trials":[387],"evolve":[389],"selection":[390],"treatment":[392],"intensification":[393],"strategies.":[394]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-11-06T00:00:00"}